Persistently High Plasma Morphine-6-Glucuronide Levels Despite Decreased Hourly Patient-Controlled Analgesia Morphine Use After Single-Dose Diclofenac
- 1 May 1999
- journal article
- regional anesthesia-and-pain-management
- Published by Ovid Technologies (Wolters Kluwer Health) in Anesthesia & Analgesia
- Vol. 88 (5), 1137-1142
- https://doi.org/10.1097/00000539-199905000-00032
Abstract
We studied the time course of clinical and pharmacokinetic effects after the rectal administration of diclofenac 100 mg in seven patients using patient-controlled morphine (PCA) on the first postoperative day after major spinal surgery. Plots of plasma diclofenac concentrations and pain intensity difference (PID) demonstrated counterclockwise hysteresis consistent with distribution to a central effect compartment such as the central nervous system. Mean +/- SEM (range) maximum PID and its timing were 62% +/- 10% (32%-98%) and 309 +/- 20 (210-360) min after the administration of diclofenac, respectively. Minimal respiratory rates were significantly slower after the administration of diclofenac (P < 0.001), occurring at 197 +/- 51.9 (60-360) min; arterial desaturations occurred in two patients without oxygen therapy. Plasma morphine and morphine-6-glucuronide (M6G) concentrations interpolated to the average time of minimal respiratory rate indicated decreases of 23% +/- 13% (0%-79%) and 1% +/- 9% (0%-32%) from their respective starting values. Plasma M6G concentrations were significantly different from baseline only 420 and 480 min after the administration of diclofenac. The potential opioid-sparing effects of a nonsteroidal antiinflammatory drug added during PCA morphine use may not be manifest for several hours. During this lag, plasma concentrations of M6G may reach and remain at levels high enough to increase the risk of respiratory depression and other opioid side effects for hours. Implications: Plasma concentrations of morphine, morphine-6-glucuronide, and diclofenac were measured postoperatively after a single dose of rectal diclofenac 100 mg was added to morphine patient-controlled analgesia. Peak analgesia occurred 309 min and respiratory depression 197 min after diclofenac administration. Morphine consumption had decreased by 20%, but concentrations of the active metabolite morphine-6-glucuronide were unchanged. Vigilance is recommended in patients receiving patient-controlled analgesia opioids and nonsteroidal antiinflammatory drugs. (Anesth Analg 1999;88:1137-42)Keywords
This publication has 17 references indexed in Scilit:
- A Rapid High Performance Liquid Chromatographic Assay for the Measurement of Diclofenac in Human PlasmaJournal of Liquid Chromatography, 1995
- The Spinal Actions of Nonsteroidal Anti-Inflammatory Drugs and the Dissociation between their Anti-Inflammatory and Analgesic EffectsDrugs, 1994
- Simple method for the determination of morphine and its active glucuronide metabolite in human plasma by high-performance liquid chromatography with electrochemical detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Central effect of the non-steroid anti-inflammatory agents, indometacin, ibuprofen, and diclofenac, determined in C fibre-evoked activity in single neurones of the rat thalamusPain, 1990
- Serum concentration and dose-response relationships for carprofen in rheumatoid arthritisClinical Pharmacology & Therapeutics, 1988
- Diclofenac SodiumDrugs, 1988
- The correlation between blood levels of ibuprofen and clinical analgesic responseCancer Cell, 1986
- Patient-controlled Analgesic Therapy, Part IVClinical Pharmacokinetics, 1982
- Patient-controlled Analgesic Therapy, Part IIClinical Pharmacokinetics, 1982
- Relationship Between Blood Meperidine Concentrations and Analgesic ResponseAnesthesiology, 1980